- Report
- January 2025
- 220 Pages
Global
From €4362EUR$4,995USD£3,790GBP
- Report
- July 2025
- 101 Pages
Europe
From €3450EUR$3,950USD£2,997GBP
- Report
- December 2024
- 85 Pages
India
From €3057EUR$3,500USD£2,655GBP
- Report
- August 2022
- 111 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- August 2022
- 115 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- April 2023
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- July 2024
- 168 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- February 2023
- 221 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- January 2024
- 352 Pages
Global
€4362EUR$4,995USD£3,790GBP
- Report
- July 2023
- 96 Pages
Middle East, Africa
From €1310EUR$1,500USD£1,138GBP
- Report
- September 2023
- 270 Pages
Global
€4187EUR$4,795USD£3,638GBP
The Intravenous Drug market is a subset of the Medical Devices industry, focusing on the delivery of drugs and other treatments through intravenous (IV) injection. This method of drug delivery is used to treat a variety of medical conditions, including infections, cancer, and chronic diseases. It is also used to provide nutrition and hydration to patients who are unable to take in food or liquids orally.
IV drug delivery systems are designed to ensure accurate and safe administration of drugs, and typically include a drug delivery device, such as a syringe, pump, or catheter, and a drug container. These systems are designed to reduce the risk of medication errors and to improve patient safety.
The Intravenous Drug market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., and Smiths Medical. Show Less Read more